Literature DB >> 26517532

c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death.

R Wu1,2, H Chen1,3, J Ma1,2, Q He1,2, Q Huang4, Q Liu5, M Li4, Z Yuan1,2,3.   

Abstract

Oxidative stress is a major cause of sporadic Parkinson's disease (PD). Here, we demonstrated that c-Abl plays an important role in oxidative stress-induced neuronal cell death. C-Abl, a nonreceptor tyrosine kinase, was activated in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-induced acute PD model. Conditional knockout of c-Abl in neurons or treatment of mice with STI571, a c-Abl family kinase inhibitor, reduced the loss of dopaminergic neurons and ameliorated the locomotive defects induced by short-term MPTP treatment. By combining the SILAC (stable isotope labeling with amino acids in cell culture) technique with other biochemical methods, we identified p38α as a major substrate of c-Abl both in vitro and in vivo and c-Abl-mediated phosphorylation is critical for the dimerization of p38α. Furthermore, p38α inhibition mitigated the MPTP-induced loss of dopaminergic neurons. Taken together, these data suggested that c-Abl-p38α signaling may represent a therapeutic target for PD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26517532      PMCID: PMC5072446          DOI: 10.1038/cdd.2015.135

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  31 in total

Review 1.  Activation and signaling of the p38 MAP kinase pathway.

Authors:  Tyler Zarubin; Jiahuai Han
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

2.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation.

Authors:  E Casanova; S Fehsenfeld; T Mantamadiotis; T Lemberger; E Greiner; A F Stewart; G Schütz
Journal:  Genesis       Date:  2001-09       Impact factor: 2.487

Review 3.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

4.  c-Jun N-terminal kinase enhances MST1-mediated pro-apoptotic signaling through phosphorylation at serine 82.

Authors:  Wenzhi Bi; Lei Xiao; Yunfeng Jia; Junbing Wu; Qi Xie; Jian Ren; Guangju Ji; Zengqiang Yuan
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

5.  The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.

Authors:  S B Marley; M W Deininger; R J Davidson; J M Goldman; M Y Gordon
Journal:  Exp Hematol       Date:  2000-05       Impact factor: 3.084

6.  c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14.

Authors:  Amy R Sanguinetti; Cynthia Corley Mastick
Journal:  Cell Signal       Date:  2003-03       Impact factor: 4.315

7.  Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.

Authors:  A Gotoh; K Miyazawa; K Ohyashiki; T Tauchi; H S Boswell; H E Broxmeyer; K Toyama
Journal:  Exp Hematol       Date:  1995-10       Impact factor: 3.084

8.  Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response.

Authors:  Cheng Cao; Yumei Leng; Chufang Li; Donald Kufe
Journal:  J Biol Chem       Date:  2003-02-04       Impact factor: 5.157

9.  c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.

Authors:  Anne-Laure Mahul-Mellier; Bruno Fauvet; Amanda Gysbers; Igor Dikiy; Abid Oueslati; Sandrine Georgeon; Allan J Lamontanara; Alejandro Bisquertt; David Eliezer; Eliezer Masliah; Glenda Halliday; Oliver Hantschel; Hilal A Lashuel
Journal:  Hum Mol Genet       Date:  2014-01-09       Impact factor: 5.121

10.  Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models.

Authors:  Michaeline L Hebron; Irina Lonskaya; Charbel E-H Moussa
Journal:  Hum Mol Genet       Date:  2013-05-10       Impact factor: 6.150

View more
  25 in total

1.  Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia.

Authors:  Jinbo Cheng; Yajin Liao; Lei Xiao; Rong Wu; Siqi Zhao; Hong Chen; Baidong Hou; Xia Zhang; Chengyu Liang; Yun Xu; Zengqiang Yuan
Journal:  Cell Death Differ       Date:  2016-11-04       Impact factor: 15.828

Review 2.  The c-Abl inhibitor in Parkinson disease.

Authors:  Zhi-Hua Zhou; Yun-Fan Wu; Xue-Min Wang; Yong-Zhu Han
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

3.  Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.

Authors:  Jinbo Cheng; Yajin Liao; Yuan Dong; Han Hu; Nannan Yang; Xiangxi Kong; Shuoshuo Li; Xiaoheng Li; Jifeng Guo; Lixia Qin; Jiezhong Yu; Cungen Ma; Jianke Li; Mingtao Li; Beisha Tang; Zengqiang Yuan
Journal:  Autophagy       Date:  2020-01-31       Impact factor: 16.016

4.  Levo-tetrahydropalmatine Attenuates Neuron Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury: Involvement of c-Abl Activation.

Authors:  Ruoxi Sun; Yichen Song; Shanshan Li; Zhanqiang Ma; Xueyang Deng; Qiang Fu; Rong Qu; Shiping Ma
Journal:  J Mol Neurosci       Date:  2018-07-04       Impact factor: 3.444

Review 5.  Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative Diseases.

Authors:  Anshuman Singh; Shubham Upadhayay; Sidharth Mehan
Journal:  Neurotox Res       Date:  2021-08-25       Impact factor: 3.911

6.  c-Abl Tyrosine Kinase-Mediated Neuronal Apoptosis in Subarachnoid Hemorrhage by Modulating the LRP-1-Dependent Akt/GSK3β Survival Pathway.

Authors:  Cong Yan; Yao Liu; Hongwei Yu; Pei Wu; Chunlei Wang; Hongbo Zhao; Kongbin Yang; Qi Shao; Yingqiang Zhong; Wenyang Zhao; Jingwei Li; Nan Liu; Jinglong Di; Chen Li; Luhao Bao; Cheng Gao
Journal:  J Mol Neurosci       Date:  2021-03-30       Impact factor: 3.444

7.  The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson's Disease by Inhibiting the NF-κB/NLRP3 Pathway.

Authors:  Shuhan Liu; Shengxiang Wang; Runze Gu; Na Che; Jing Wang; Jinbo Cheng; Zengqiang Yuan; Yong Cheng; Yajin Liao
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

8.  Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.

Authors:  Saurav Brahmachari; Preston Ge; Su Hyun Lee; Donghoon Kim; Senthilkumar S Karuppagounder; Manoj Kumar; Xiaobo Mao; Joo Ho Shin; Yunjong Lee; Olga Pletnikova; Juan C Troncoso; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  J Clin Invest       Date:  2016-06-27       Impact factor: 14.808

9.  c-Abl inhibition mitigates diet-induced obesity through improving insulin sensitivity of subcutaneous fat in mice.

Authors:  Rong Wu; Jian-Guang Sun; Ji-Qiu Wang; Binhua Li; Qingsong Liu; Guang Ning; Wanzhu Jin; Zengqiang Yuan
Journal:  Diabetologia       Date:  2017-01-10       Impact factor: 10.122

10.  c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential.

Authors:  Saurav Brahmachari; Senthilkumar S Karuppagounder; Preston Ge; Saebom Lee; Valina L Dawson; Ted M Dawson; Han Seok Ko
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.